Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic medicine is accelerating in Japan.
Hayashi S, Kubo M, Kaneshiro K, Kai M, Yamada M, Morisaki T, Takao Y, Shimazaki A, Shikada S, Nakamura M. Hayashi S, et al. Among authors: morisaki t. Breast Cancer. 2022 Jul;29(4):659-665. doi: 10.1007/s12282-022-01342-4. Epub 2022 Feb 21. Breast Cancer. 2022. PMID: 35191009 Free PMC article.
Significance of the Multi-gene Panel myRisk in Japan.
Hayashi S, Kubo M, Matsuzaki S, Kai M, Morisaki T, Yamada M, Kaneshiro K, Takao Y, Shimazaki A, Nagayoshi K, Mizuuchi Y, Nakamura M. Hayashi S, et al. Among authors: morisaki t. Anticancer Res. 2022 Aug;42(8):4097-4102. doi: 10.21873/anticanres.15907. Anticancer Res. 2022. PMID: 35896222
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.
Zaguirre K, Kai M, Kubo M, Yamada M, Kurata K, Kawaji H, Kaneshiro K, Harada Y, Hayashi S, Shimazaki A, Morisaki T, Mori H, Oda Y, Chen S, Moriyama T, Shimizu S, Nakamura M. Zaguirre K, et al. Among authors: morisaki t. Cancer Med. 2021 Mar;10(5):1605-1613. doi: 10.1002/cam4.3713. Epub 2021 Jan 15. Cancer Med. 2021. PMID: 33452761 Free PMC article.
Neoantigens elicit T cell responses in breast cancer.
Morisaki T, Kubo M, Umebayashi M, Yew PY, Yoshimura S, Park JH, Kiyotani K, Kai M, Yamada M, Oda Y, Nakamura Y, Morisaki T, Nakamura M. Morisaki T, et al. Sci Rep. 2021 Jun 30;11(1):13590. doi: 10.1038/s41598-021-91358-1. Sci Rep. 2021. PMID: 34193879 Free PMC article. Clinical Trial.
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites.
Morisaki T, Hikichi T, Onishi H, Morisaki T, Kubo M, Hirano T, Yoshimura S, Kiyotani K, Nakamura Y. Morisaki T, et al. Immunol Invest. 2021 Jul;50(5):562-579. doi: 10.1080/08820139.2020.1778721. Epub 2020 Jul 13. Immunol Invest. 2021. PMID: 32660279
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.
Morisaki T, Morisaki T, Kubo M, Onishi H, Hirano T, Morisaki S, Eto M, Monji K, Takeuchi A, Nakagawa S, Tanaka H, Koya N, Umebayashi M, Tsujimura K, Yew PY, Yoshimura S, Kiyotani K, Nakamura Y. Morisaki T, et al. Among authors: morisaki s. Anticancer Res. 2021 Aug;41(8):4101-4115. doi: 10.21873/anticanres.15213. Anticancer Res. 2021. PMID: 34281881
632 results